Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers

Cancer Immunology, Immunotherapy

Volumn 52, Issue 4, 2003, Pages 226-234

  Graner, Michael W ^a   Zeng, Yi ^a   Feng, Hanping ^a   Katsanis, Emmanuel ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer immunotherapy; Chaperone rich cell lysates; Dendritic cells; Heat shock chaperone proteins

Indexed keywords

CANCER VACCINE; CHAPERONE; CHAPERONE RICH CELL LYSATE VACCINE; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN 70; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODIVERSITY; CANCER IMMUNOTHERAPY; CELL LYSATE; CELL SURVIVAL; CHAPERONE RICH CELL LYSATE; CLINICAL RESEARCH; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; DRUG MANUFACTURE; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; GROWTH INHIBITION; IN VIVO STUDY; ISOELECTRIC FOCUSING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRODUCT RECOVERY; PRODUCTIVITY; PROTEIN PURIFICATION; QUANTITATIVE ASSAY; TUMOR GROWTH; VACCINATION;

EID: 0038408927     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0359-2     Document Type: Article

References (30)

1. Anderson KM, Srivastava PK (2000) Heat, heat shock, heat shock proteins and death: central link in innate and adaptive immune responses. Immunol Lett 74: 35
2. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee HG, de la Salle H, Schild H (1999) Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162: 3757
3. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK (2000) HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6: 435
4. Basu S, Srivastava, PK (1999) Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med 189: 797
5. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin. Immunity 14: 303
6. Binder RJ, Han DK, Srivastava PK (2000) CD91: a receptor for heat shock protein gp96. Nat Immunol 1: 151
7. Blachere NE, Udono H, Janetzki S, Li Z, Heike M, Srivastava PK (1993) Heat shock protein vaccines against cancer. J Immunother 14: 352
8. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, Germain RN (2000) Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 191: 1957
9. Caudill MM, Li Z (2001) HSPPC-96: a personalised cancer vaccine. Expert Op Biol Therapy 1: 539
10. Feng H, Zeng Y, Whitesell L, Katsanis E (2001) Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood 97: 3505
11. Feng H, Zeng Y, Graner M, Katsanis E (2002) Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100:4108
12. Feng H, Zeng Y, Graner M, Likhacheva A, Katsanis E (2003) Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate anti-tumor immunity. Blood 101:245
13. Graner M, Raymond A, Romney D, He L, Whitesell L, Katsanis E (2000) Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma. Clin Can Res 6: 909
14. Graner M, Raymond A, Akporiaye E, Katsanis E (2000) Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines. Cancer Immunol Immunother 49: 476
15. He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M, Whitesell L, Katsanis E (2001) Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice. Cancer Immunol Immunother 50: 31
16. Heike M, Weinmann A, Bethke K, Galle PR (1999) Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines. Biochem Pharmacol 58: 1381
17. Janetzki S, Palla D, Rosenhauer V, Lochs H, Lewis JJ, Srivastava PK (2000) Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer 88: 232
18. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457
19. Li Z (1997) Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines. Semin Immunology 9: 315
20. Nair S, Wearsch PA, Mitchell DA, Wassenberg JJ, Gilboa E, Nicchitta CV (1999) Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. J Immunol 162: 6426
21. Peto R, Peto J (1972) Asymptotically efficient rank invariant procedures. J Roy Stat Soc A135: 185
22. Singh-Jasuja H, Toes RE, Spee P, Munz C, Hilf N, Schoenberger SP, Ricciardi-Castagnoli P, Neefjes J, Rammensee HG, Arnold-Schild D, Schild H (2000) Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 191: 1965
23. Somersan S, Larsson M, Fonteneau JF, Basu S, Srivastava P, Bhardwaj N (2001) Primarytumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J Immunol 167: 4844
24. Srivastava PK, Menoret A, Basu S, Binder RJ, McQuade KL (1998) Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8: 657
25. Srivastava PK, Amato RJ (2001) Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 19: 2590
26. Tamura Y, Peng P, Daou M, Srivastava PK (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278: 117
27. Udono H, Srivastava PK (1994) Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol 152: 5398
28. Wassenberg JJ, Dezfulian C, Nicchitta CV (1999) Receptor mediated and fluid phase pathways for internalization of the ER Hsp90 chaperone GRP94 in murine macrophages. J Cell Sci 112: 2167
29. Wells AD, Malkovsky M (2000) Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today 21: 129
30. Zeng Y, Feng H, Graner MW, Katsanis E (2003) Tumor-derived chaperone-rich cell lysates stimulate dendritic cells and elicit therapeutic anti-tumor immunity. Blood (in press)